Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A multicenter, open-label, phase III, randomized, active-controlled trial evaluating the efficacy, safety, and pharmacokinetics of rhuMAb VEGF (bevacizumab), in combination with capecitabine chemotherapy, in subjects with previously treated metastatic breast cancer
bevacizumab
AVF2119G
NCT00262067
refractory metastatic breast cancer
Phase 3
 
January 2014

Powered by ideaPoint, Inc.